Seeking Alpha

Spinal implant maker NuVasive (NUVA +17%) pops after its Q1 results easily beat estimates,...

Spinal implant maker NuVasive (NUVA +17%) pops after its Q1 results easily beat estimates, coming in at the high end of the expected range. Revenue jumped 21% Y/Y on strong sales of its minimally invasive spinal surgery products. William Blair and Baird both upgrade the stock on the back of the better than expected results.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)